U S ENERGY CORP - DELAWARE (USEG)

US9118053076 - Common Stock

1.47  -0.01 (-0.68%)


Fundamental Rating

3

Overall USEG gets a fundamental rating of 3 out of 10. We evaluated USEG against 381 industry peers in the Oil, Gas & Consumable Fuels industry. USEG has a bad profitability rating. Also its financial health evaluation is rather negative. USEG is not valued too expensively and it also shows a decent growth rate.




Profitability

Profitability Rating

1

USEG has a Piotroski-F score of 6.00. This indicates an average health and profitability for USEG.
USEG's Return On Assets of 1.02% is worse than the rest of the industry. The industry average Return On Assets is 13.62%. 97% of the industry peers have a better Return On Assets.

USEG has a Return On Equity of 1.52%. This is below the industry average of 28.96%. 99% of the industry peers outperform USEG.
USEG has a Profit Margin of 2.67%. This is below the industry average of 28.48%. 95% of the industry peers outperform USEG.
VS Industry

ROA (1.02%) VS Industry: 3% outperformed.

0.14
2,236.96

ROE (1.52%) VS Industry: 1% outperformed.

0.15
22,783.17

Profit Margin (2.67%) VS Industry: 5% outperformed.

0.19
159.88

Valuation

Valuation Rating

5

The low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
With a price book ratio of 0.48, USEG is valued rather cheaply.
When comparing the price book ratio of USEG to the average industry price book ratio of 1.36, USEG is valued rather cheaply. USEG is also cheaper than 93% of the companies listed in the same industry.
Compared to an average industry Enterprise Value to EBITDA ratio of 3.65, USEG is valued in line with its industry peers.

With a Price/Earnings Ratio of 29.40, USEG can be considered very expensive at the moment.
Compared to an average industry Price/Earning Ratio of 5.48, USEG is valued more expensive than its industry peers. On top of this 97% of the companies listed in the same industry are cheaper than USEG!
With a Forward Price/Earnings Ratio of 144.12, USEG is valued very expensively.
VS Industry

Price/Earnings (29.4) VS Industry: 3% outperformed.

153.50
0.01

Price/Book (0.48) VS Industry: 93% outperformed.

4,701.10
0.04

Enterprise Value/ EBITDA (4.23) VS Industry: 43% outperformed.

235.43
0.38

Growth

Growth Rating

5

USEG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 110.16%, which is quite impressive.
The Revenue has grown by 206.95% in the past year. This is a very strong growth!

USEG shows a strong growth in Revenue. Measured over the last 5 years, the Revenue has been growing by 46.73% yearly.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A N/A 110.16% -86.67% N/A N/A N/A
Revenue46.73% 89.28% 206.95% -10.74% N/A N/A N/A

Health

Health Rating

1

The Debt to Equity ratio of USEG is in line with the industry averages.
The Piotroski-F score of USEG is 6.00. This is a neutral score and indicates average health and profitability for USEG.
USEG has a Current Ratio of 0.64. This is a bad value and indicates that USEG is not financially healthy enough and could expect problems in meeting its short term obligations.
Compared to an average industry Current Ratio of 1.12, USEG is worse placed to pay its short term obligations than its industry peers.

USEG has a Quick Ratio of 0.64. This is a bad value and indicates that USEG is not financially healthy enough and could expect problems in meeting its short term obligations.
When comparing the Quick Ratio of USEG to the average industry Current Ratio of 0.97, USEG is less able to pay its short term obligations than its industry peers.
USEG has an Altman-Z score of -0.75. This is a bad value and indicates that USEG is not financially healthy and even has some risk of bankruptcy.
When comparing the Altman-Z score of USEG to the average industry Altman-Z score of 2.07, USEG is less financially healthy than its industry peers. 86% of its industry peers have a better Altman-Z score.
VS Industry

Debt/Equity (0.16) VS Industry: 59% outperformed.

13.98
0.00

Quick Ratio (0.64) VS Industry: 25% outperformed.

0.00
186.31

Current Ratio (0.64) VS Industry: 22% outperformed.

0.00
186.31

Altman-Z (-0.75) VS Industry: 14% outperformed.

-509,914.51
326.97

Dividend

Dividend Rating

4

USEG has a Yearly Dividend Yield of 6.16%, which is a nice return.
USEG's Dividend Yield is rather good when compared to the S&P500 average which is at 2.71.
In the last 3 months the price of USEG has falen by -26.87%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.

Compared to an average industry Dividend Yield of 5.98, USEG has a dividend in line with its industry peers.
USEG is new to the dividend game and has less than 3 years of track record.
VS Industry

Dividend Yield (6.16%) VS Industry: 52% outperformed.

0.29
63.00

U S ENERGY CORP - DELAWARE

NASDAQ:USEG (6/5/2023, 7:00:03 PM)

1.47

-0.01 (-0.68%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-17 2023-05-17/amc
Earnings (Next)08-09 2023-08-09/amc
Inst Owners2.23%
Inst Owner Change4.2%
Ins Owners41.33%
Ins Owner Change5.33%
Market Cap37.10M
Analysts82.5
Price Target3.16 (114.97%)
Dividend
Industry RankSector Rank
Dividend Yield 6.16%
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-Date05-18 2023-05-18 (0.0225)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)-2060.78%
Min EPS beat(2)-2060.78%
Max EPS beat(2)-2060.78%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)-12.39%
Min Revenue beat(2)-18.19%
Max Revenue beat(2)-6.58%
Revenue beat(4)N/A
Avg Revenue beat(4)-8.7%
Min Revenue beat(4)-18.19%
Max Revenue beat(4)-1.33%
PT rev (1m)-4.62%
PT rev (3m)-17.33%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-95.65%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.16%
Valuation
Industry RankSector Rank
PE 29.4
Fwd PE 144.12
P/S 0.84
P/FCF 8.37
P/OCF 3.48
P/B 0.48
P/tB 0.48
EV/EBITDA 4.23
EPS(TTM)0.05
EY3.4%
EPS(NY)0.01
Fwd EY0.69%
FCF(TTM)0.18
FCFY11.95%
OCF(TTM)0.42
OCFY28.7%
SpS1.74
BVpS3.05
TBVpS3.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.02%
ROE 1.52%
ROIC 0.63%
ROICexc 0.65%
ROICexgc 0.65%
OM 1.92%
PM 2.67%
GM 26.91%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.57%
GM growth 5Y-2%
F-Score6
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 2.71
Debt/EBITDA 1.09
Cap/Depr 61.28%
Profit Quality 377.68%
Current Ratio 0.64
Quick Ratio 0.64
Altman-Z -0.75
F-Score6
WACC8.89%
ROIC/WACC0.07
Cap/Depr(3y)147.87%
Cap/Depr(5y)147.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
Growth
EPS 1Y110.16%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q65.29%
EPS Next Y-86.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue growth 1Y206.95%
Revenue growth 3Y89.28%
Revenue growth 5Y46.73%
Revenue growth Q2Q-6.76%
Revenue Next Year-10.74%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y304.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year135.94%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y329.74%
FCF growth 3Y153.89%
FCF growth 5YN/A
OCF growth 1Y1085.83%
OCF growth 3Y157.27%
OCF growth 5YN/A
Fundamental Stock Screener Links
Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA